相关实验视频

Updated: Jun 10, 2025

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

癌症中的淋巴结转移:清除云层,看到黎明

Zi-Zhan Li¹, Kan Zhou¹, Qiuji Wu²

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.

Critical reviews in oncology/hematology

|October 19, 2024

概括

淋巴结转移 (LNM) 是一个关键的癌症指标. 本综述阐明了LNM的分子基础,诊断挑战和治疗策略,强调了改善早期检测和管理的必要性,特别是随着免疫治疗的进步.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

淋巴结转移 (LNM) 是癌症预后的一个关键因素,但其潜在的分子机制仍然不完全理解.
三个多世纪的研究还没有完全阐明LNM的复杂性.
免疫治疗的日益使用需要对淋巴结 (LN) 状态和完整性的更深入的理解.

研究的目的:

为了清晰度,全面审查LNM的分子机制,采用"PUMP+"原则.
讨论LNM目前的诊断方法,并强调早期检测策略的必要性.
在免疫疗法和LN保存的背景下,探索LNM不断发展的治疗策略.

主要方法:

文献综述和对LNM现有研究的综合.
应用"PUMP+"原理来解释分子机制.
对LNM的诊断方式和治疗方法的分析.

主要成果:

LNM的分子机制是复杂的,并未完全定义.
病理检查是目前LNM诊断的黄金标准.
早期诊断策略和精确的治疗对于改善患者的治疗结果至关重要,特别是在免疫治疗中.

结论:

需要进一步的研究才能充分阐明LNM的分子基础.
在诊断准确性和精确治疗方面的进步对于管理LNM至关重要.
保持LN完整性越来越重要,尤其是在免疫治疗开始之前.

关键词:

癌症癌症癌症癌症癌症预后癌症预后免疫治疗是一种免疫疗法.淋巴结转移是淋巴结的转移.

更多相关视频

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...